Carcillo Joseph A, Dean J Michael, Holubkov Richard, Berger John, Meert Kathleen L, Anand Kanwaljeet J S, Zimmerman Jerry, Newth Christopher J, Harrison Rick, Burr Jeri, Willson Douglas F, Nicholson Carol, Bell Michael J, Berg Robert A, Shanley Thomas P, Heidemann Sabrina M, Dalton Heidi, Jenkins Tammara L, Doctor Allan, Webster Angie
From the *Department of Critical Care Medicine and Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania; †Department of Pediatrics, University of Utah, Salt Lake City, Utah; ‡Department of Pediatrics, George Washington University, Washington, DC; §Department of Pediatrics, Wayne State University, Detroit, Michigan; ¶Department of Pediatrics, University of Arkansas, Fayetteville, Arkansas; ‖Department of Pediatrics, University of Washington, Washington, DC; **Department of Pediatrics, University of Southern California, Los Angeles, CA; ††Department of Pediatrics, University of California at Los Angeles, Los Angeles, CA; ‡‡Department of Pediatrics, University of Virginia, Charlottesville, Virginia; §§Eunice Kennedy Shriver National Institutes of Child Health and Development, Rockville, Maryland; ¶¶Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania; ‖‖Department of Pediatrics, University of Michigan, Ann Arbor, Michigan; ***Department of Pediatrics, University of Arizona, Tucson, Arizona; and †††Department of Pediatrics, Washington University at St. Louis, St. Louis, Missouri.
Pediatr Infect Dis J. 2016 Nov;35(11):1182-1186. doi: 10.1097/INF.0000000000001286.
Nosocomial infection remains an important health problem in long stay (>3 days) pediatric intensive care unit (PICU) patients. Admission risk factors related to the development of nosocomial infection in long stay immune competent patients in particular are not known.
Post-hoc analysis of the previously published Critical Illness Stress induced Immune Suppression (CRISIS) prevention trial database, to identify baseline risk factors for nosocomial infection. Because there was no difference between treatment arms of that study in nosocomial infection in the population without known baseline immunocompromise, both arms were combined and the cohort that developed nosocomial infection was compared with the cohort that did not.
There were 254 long stay PICU patients without known baseline immunocompromise. Ninety (35%) developed nosocomial infection, and 164 (65%) did not. Admission characteristics associated with increased nosocomial infection risk were increased age, higher Pediatric Risk of Mortality version III score, the diagnoses of trauma or cardiac arrest and lymphopenia (P < 0.05). The presence of sepsis or infection at admission was associated with reduced risk of developing nosocomial infection (P < 0.05). In multivariable analysis, only increasing age, cardiac arrest and existing lymphopenia remained significant admission risk factors (P < 0.05); whereas trauma tended to be related to nosocomial infection development (P = 0.07).
These data suggest that increasing age, cardiac arrest and lymphopenia predispose long stay PICU patients without known baseline immunocompromise to nosocomial infection. These findings may inform pre-hoc stratification randomization strategies for prospective studies designed to prevent nosocomial infection in this population.
医院感染仍是长期住院(>3天)儿科重症监护病房(PICU)患者面临的一个重要健康问题。尤其是长期住院且免疫功能正常的患者发生医院感染的相关入院风险因素尚不清楚。
对先前发表的危重病应激诱导免疫抑制(CRISIS)预防试验数据库进行事后分析,以确定医院感染的基线风险因素。由于该研究中在无已知基线免疫功能低下的人群中,各治疗组在医院感染方面无差异,因此将两组合并,并将发生医院感染的队列与未发生医院感染的队列进行比较。
有254例长期住院的PICU患者无已知基线免疫功能低下。90例(35%)发生医院感染,164例(65%)未发生。与医院感染风险增加相关的入院特征包括年龄增加、儿科死亡风险评分第三版升高、创伤或心脏骤停诊断以及淋巴细胞减少(P<0.05)。入院时存在脓毒症或感染与发生医院感染的风险降低相关(P<0.05)。在多变量分析中,只有年龄增加、心脏骤停和现有的淋巴细胞减少仍然是显著的入院风险因素(P<0.05);而创伤往往与医院感染的发生有关(P=0.07)。
这些数据表明,年龄增加、心脏骤停和淋巴细胞减少使无已知基线免疫功能低下的长期住院PICU患者易发生医院感染。这些发现可能为旨在预防该人群医院感染的前瞻性研究的事前分层随机化策略提供参考。